Posted on April 19, 20214/19/21
Two Bills Aiming to Lower Prescription Drug Costs Await Signatures from Biden
Posted on April 15, 20214/15/21
ICER Utilizes Real World Evidence to Update Assessment of HAE Attack Prophylactics Takhzyro, Haegarda, Cinryze
Posted on April 13, 20214/13/21
Meeting on the Meds | Ultra-Orphan Drugs Should Be First Area of Focus for Regulatory Alignment, Say Drug Regulators
Posted on April 9, 20214/9/21
Malta MEP Saliba Urges EU Intervention to Ensure Affordable Medicines for Smallest Member States
Posted on April 8, 20214/8/21
Spanish SEFC Eyes Up Drug Evaluation Overhaul Through “Multidisciplinary Collaboration”
Posted on April 5, 20214/5/21
Last Week in Review: 3/29/2021 – 4/2/2021
Posted on April 2, 20214/2/21
IQWiG Tasked by G-BA to Collect Application-Related Data on CAR-T Therapies
Posted on March 31, 20213/31/21
AIFA Introduces Simplified Pricing, Reimbursement Negotiation Procedure for Parallel Imported Drugs
Posted on March 29, 20213/29/21
U.S. Senators Reintroduce FAIR Drug Pricing Act Requiring Transparency Surrounding Drug Price Increases
Posted on March 29, 20213/29/21